Beijing Demo High-Tech Pharmaceutical Technology

Beijing Demo High-Tech Pharmaceutical Technology is a China-based biotechnology company focused on the research and development of innovative small molecule drugs, particularly for metabolic and endocrine diseases. The company specializes in the development of treatments for type 2 diabetes and obesity, with a pipeline that includes GLP-1 receptor agonists and other metabolic regulators. In addition to its internal drug discovery programs, Beijing Demo provides pharmaceutical R&D services and technical consulting. The firm operates out of the Beijing Zhongguancun Life Science Park, leveraging local expertise to advance its clinical-stage candidates through the regulatory process in China.